Cognitive impairment/dementia

There are 5 papers on cognitive impairment/dementia in aging research: none in people yet, 5 reviews. The newest story, Nov 2, 2026: “COVID-19 linked to cognitive problems years after infection”.

Disease

5 papers study it49 more mention it11 findings

4 new papers in 30 daysSee all 54 papers on cognitive impairment/dementia

“CKD patients with CI had higher all-cause mortality (18.5% vs 12.6%)”
Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysisClinical kidney journal2024doi:10.1093/ckj/sfae401

Interventions

3

PCSK9 inhibitors

no changein humans1OR 1.77

1 study
  1. PCSK9 inhibitors showed no clear effect on cognitive impairment/dementia in humans (subgroup by drug class, randomized trials) (OR 1.77; 95% CI 0.46-6.83).

    “PCSK9 inhibitor: OR 1.77; 95% CI, 0.46-6.83”

    Human trialsubgroup by drug class, randomized trials

    Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis

    Age and ageing

More on PCSK9 inhibitors

Statins

no changein humans1OR 0.9

1 study
  1. Statins showed no clear effect on cognitive impairment/dementia in humans (subgroup by drug class, randomized trials) (OR 0.90; 95% CI 0.67-1.21).

    “There was no significant association amongst drug classes (Statin; OR 0.90; 95% CI, 0.67-1.21”

    Human trialsubgroup by drug class, randomized trials

    Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis

    Age and ageing

More on Statins

Lipid-lowering therapy

no changein humans1OR 0.96

1 study
  1. Lipid-lowering therapy showed no clear effect on cognitive impairment/dementia in humans (compared with control in randomized trials, random effects pooled) (OR 0.96; 95% CI 0.74-1.26; 1.33% vs 1.36%).

    “Lipid-lowering therapy compared with control was not associated with a significant reduction in dementia or cognitive impairment”

    Human trialcompared with control in randomized trials, random effects pooledmean trial follow-up 34.5 monthsn = 139,169

    Association of lipid-lowering therapy with dementia and cognitive outcomes: a systematic review and meta-analysis

    Age and ageing

More on Lipid-lowering therapy

Associations

8

Oophorectomy

upin humans1

1 study
  1. Oophorectomy is associated with cognitive impairment/dementia in humans (Ovarian hormone loss after premenopausal bilateral oophorectomy).

    “several observational studies have associated this change with a higher risk of later cognitive impairment or dementia, particularly when surgery is performed at a younger age.”

    ReviewOvarian hormone loss after premenopausal bilateral oophorectomybilateralfemales

    The Interplay Between Oophorectomy and Alzheimer's Disease: A Narrative Review

    Medicina (Kaunas, Lithuania)

More on Oophorectomy

Diabetic retinopathy

no changein humans1OR 1.07

1 study
  1. Diabetic retinopathy is associated with cognitive impairment/dementia in humans (Patients with diabetes mellitus; crude dichotomous synthesis of seven studies) (OR 1.07, 95% CI 0.94-1.23).

    “did not demonstrate a statistically significant association between diabetic retinopathy and cognitive impairment or dementia”

    ReviewPatients with diabetes mellitus; crude dichotomous synthesis of seven studies

    The association between diabetic retinopathy and cognitive impairment in patients with diabetes mellitus: a systematic review and meta-analysis

    Frontiers in endocrinology

More on Diabetic retinopathy

Number of care needs

upin humans1

1 study
  1. Cognitive impairment/dementia is associated with number of care needs in humans (Cognitive impairment/dementia compared with the healthy population).

    “People with cognitive impairment/dementia had a higher number of needs compared to the healthy population.”

    HumansCognitive impairment/dementia compared with the healthy populationn = 368

    Needs assessment of people living with cognitive impairment/dementia, a requirement of comprehensive psychogeriatric assessment and person-centered care. Empirical validation of the model in a community study

    Frontiers in psychiatry

Encephalopathy

upin humans1

1 study
  1. Cognitive impairment/dementia is linked with a higher risk of encephalopathy in CKD patients (stages 3-5), propensity-score-matched cohorts (9.9% vs 5.0%).

    “encephalopathy (9.9% vs 5.0%)”

    Humansin CKD patients (stages 3-5), propensity-score-matched cohortsmean follow-up 23.2 monthsn = 8,170

    Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis

    Clinical kidney journal

More on Encephalopathy

Cerebrovascular disease

upin humans1

1 study
  1. Cognitive impairment/dementia is linked with a higher risk of cerebrovascular disease in CKD patients (stages 3-5), propensity-score-matched cohorts (11.3% vs 6.9%).

    “higher risk of cerebrovascular disease (11.3% vs 6.9%)”

    Humansin CKD patients (stages 3-5), propensity-score-matched cohortsmean follow-up 23.2 monthsn = 8,170

    Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis

    Clinical kidney journal

More on Cerebrovascular disease

Mortality

upin humans1

1 study
  1. Cognitive impairment/dementia is linked with a higher risk of mortality in CKD patients (stages 3-5), propensity-score-matched cohorts (18.5% vs 12.6%).

    “CKD patients with CI had higher all-cause mortality (18.5% vs 12.6%)”

    Humansin CKD patients (stages 3-5), propensity-score-matched cohortsmean follow-up 23.2 monthsn = 8,170

    Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis

    Clinical kidney journal

Acute kidney injury

upin humans1OR 1.87

1 study
  1. Acute kidney injury is associated with cognitive impairment/dementia in humans (OR 1.87, 95% CI 1.77–1.98).

    “Patients with AKI were at higher risk of cognitive impairment or dementia compared to those who had not experienced AKI”

    Reviewn = 423,876

    Association of acute kidney injury with the risk of cognitive impairment or dementia: a systematic review and meta-analysis

    Renal failure

More on Acute kidney injury

Antidepressants

upin humans1OR 2.17

1 study
  1. Antidepressants are associated with cognitive impairment/dementia in humans (OR = 2.17).

    “Use of antidepressant drugs was associated with a significant twofold increase in the odds of some form of cognitive impairment or dementia (OR = 2.17).”

    Review

    The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis

    Depression and anxiety

More on Antidepressants

Funding

7 grants since 2018

National Institute on Aging$2.6MNational Institute of Neurological Disorders and Stroke$2.3MNational Health and Medical Research CouncilA$1.5M

Latest

Dec 2025: 2Jan 2026: 2Feb 2026: 0Mar 2026: 3Apr 2026: 1May 2026: 1Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 3Nov 2026: 115 papers in 12 months
medRxiv

COVID-19 linked to cognitive problems years after infection

In the pre-vaccination cohort, diagnoses of memory and thinking problems had a relative rate of 4.02 within four weeks after COVID-19 versus before or without infection.In the pre-vaccination cohort, diagnoses of memory and thinking problems had a relative rate of 4.02 within four weeks after COVID-19 versus before or without infection.

Preprint: cohort · 18,300,000 peopleCOVID-19

See all 54 papers on cognitive impairment/dementia